Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2021

Mar 11, 2021

3091_iss_2021-03-11_3fecc5df-87a2-4871-8f7c-b0811d634765.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares 0
Voting rights 0
Transaction
Reason for major shareholding notification Share loan
Date 10/03/2021
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 3,920,805
Directly held voting rights 3,920,805
Indirectly held voting rights 0
Percentage
Directly held shares 5.7587 %
Directly held voting rights 5.7587 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.7587 % 3,920,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
5.14065 % 3,500,000
- Physically settled
- Cash settled
Total 10.89935 % 7,420,805

Group total holdings

Voting rights 3,920,805 Percentage of voting rights 5.7587

Notes (other relevant informations according to law)

Flaggningen avser utlån av aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 68 084 855 utestående aktier i Oncopeptides per 10 mars 2021, dagen då flaggningsskyldigheten uppstod.

Published

11/03/2021 14:02

Contact

Name Jonas Brambeck

Phone +46 70 879 19 37 Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25